US 12109258
Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections
granted A61KA61K2039/53A61K2039/55527
Quick answer
US patent 12109258 (Synthetic malaria immunogens, combinations thereof, and their use to prevent and treat malaria infections) held by Inovio Pharmaceuticals, Inc. expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Inovio Pharmaceuticals, Inc.
- Grant date
- Tue Oct 08 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/53, A61K2039/55527, A61K2039/55538, A61K39/015